Business Standard

Friday, December 20, 2024 | 01:17 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

PharmEasy calls off its public offer; to go for rights issue instead

API Holdings, the parent company of PharmEasy, wrote to shareholders announcing withdrawal of DRHP

PharmEasy
Premium

Photo: Shutterstock

Sohini Das Mumbai
API Holdings, the parent firm of online pharmacy PharmEasy, has decided to withdraw its draft red herring prospectus (DRHP) filed with Securities and Exchange Board of India (Sebi), citing volatile market conditions and ‘strategic considerations’. The DRHP was filed on November 9, 2021.

The company has informed its shareholders that it has decided to go ahead with a rights issue instead. 

Further, API Holdings stated that the rights issue is planned around the first week of September and shall have compulsory convertible preference shares (CCPS) on offer. The issue price would be set at Rs 100 per CCPS.

According to media reports, PharmEasy

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in